Historical lifetimes of drugs in England: application to value of information and cost-effectiveness analyses.

@article{Hoyle2010HistoricalLO,
  title={Historical lifetimes of drugs in England: application to value of information and cost-effectiveness analyses.},
  author={Martin W. Hoyle},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2010},
  volume={13 8},
  pages={885-92}
}
OBJECTIVES The expected lifetime of a health technology is a critical parameter in value of information analysis and in two methodologies for cost-effectiveness analysis which have recently been suggested. The first method allows for the possibility that a superior technology will become available in the future. The second advocates modeling both the prevalent and all future incident patient cohorts. Unfortunately, for value of information analysis, the period of time over which information… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts.

Medical decision making : an international journal of the Society for Medical Decision Making • 2010

Taking account of future

JA Salomon, MC Weinstein, SJ. Goldie
books_and_monographs.htm [Accessed December • 2009

The half-life of truth: what are appropriate time horizons for research decisions?

Medical decision making : an international journal of the Society for Medical Decision Making • 2008

Expected value of sample information calculations in medical decision modeling.

Medical decision making : an international journal of the Society for Medical Decision Making • 2004

Similar Papers

Loading similar papers…